Ayurved can be helpful to improve long term survival in chronic coronary artery disease patients

Ayurved can be helpful to improve long term survival in chronic coronary - thisweekindia

We want to ‘Heal The World’ through our scientific evidence based Ayurveda, says Dr Rohit Sane

Bengaluru, 20 DEC 22: In a major breakthrough, a research conducted by Madhavbaug, The study was done over a period of three years on 572 patients with various comorbidities like chronic heart failure, post myocardial infarction, hypertension, obesity, arthritis and diabetes among others.

Explaining the findings of the study before the participants at the recently concluded an Ayurveda specialist in treating and managing cardio metabolic disorders has revealed that Ayurveda treatment and therapies are equally beneficial to modern medicines in significantly reducing various risk factors posing threat to the smooth functioning of the heart. The study also found that the hospitalisation and long-term (36 months) mortality rate among heart patients who sought Ayurveda remedies was 5.08% even after 36 Months, while hospitalization due to Heart attack was 9.09% so the outcomes are are as good as Modern Science.

In the past ISCEMIA trial was conducted to understand comparative long term survival benefit to post Angioplasty in comparison with only medication group for management of stable coronary artery disease, PTCA and only medicine hospitalization was 13.3% and 15.5% respectively, as well Mortality rate after PTCA and Allopathy Medication over 36 months is 6.4%and 6.5% respectively.

9th World Ayurveda Congress held in Panjim, Goa, Dr Rohit Sane, founder of Madhavbaug said heart patients who took Panchakarma therapies and followed strict Current data of Ayurveda diet coupled with mild exercises like Pranayama and meditation showed a significant improvement in lipid profile and an average 29 per cent reduction Blockages studied with quantitative CT coronary angiography.

Prime Minister Narendra Modi, who visited the Madhavbaug’s exhibition stall after inaugurating the 9th World Ayurveda Congress, was also briefed by Dr Sane about their heart and diabetes disease Management programmes.

“Our ancient healing science is underutilised in terms of reducing the mortality and hospitalisation due to coronary artery disease. Our clinical studies showed that non-invasive and low cost Ayurveda remedies are also effective in combating cardiac ailments. We want to make Ayurveda the first line of treatment for critical illness including cardiac ailments. We want to ‘Heal The World’ through our scientific evidence based Ayurveda,” said Dr Rohit Sane, founder, Madhavbaug.

The patients who participated in the study were put under strict dietary management for three months. They were asked to follow a high ORAC value diet to control inflammation and reverse accumulated cholesterol. They were also administered 21 Panchakarma therapies during the period.

Recent Research article accepted by the Annals of clinical cardiology demonstrate that post Ayurveda and diet modification 36 months of hospitalisation for heart attack was 9.09% while Mortality rate over 36 moths is 5.08%.

Ayurveda treatment and diet can be beneficial to prevent hospitalisation due to Heart attack and improve long term survival in coronary artery disease patients.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore